Review of medication adherence in children and adults with ADHD

Postgraduate Medicine

Volumn 122, Issue 1, 2010, Pages 184-191

  Adler, Lisa D ^a   Nierenberg, Andrew A ^b  

^a Department of Obstetrics Gynecology   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ADHD; Continuity; Discontinuity; Medication adherence; Psychostimulants

Indexed keywords

METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; REVIEW; SCHOOL CHILD; TREATMENT FAILURE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; METHYLPHENIDATE; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 76249116672     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.01.2112     Document Type: Review

References (19)

1. Kessler RC. Adler LA. Barkley R. et at. The prevalence and correlates of adult ADHD in the United States: results from the National Comorhidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723.
2. Adler LA, Cohen J. Diagnosis and evaluation of adults with attention- deficit/hyperactivity disorder. Psychiatr Clin N Am. 2004;27:187-201.
3. Adler LA, Chua HC. Management of ADHD in adults. J Clin Psychiatry. 2002;63(suppl 12):29-35.
4. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, NY: Guilford Press; 1998.
5. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: 2003:18.
6. Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care. 2006;44(4):300-303.
7. Sanchez RJ, Crismon ML. Barner JC. Bettinger T. Wilson JP. Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy. 2005;25(7):909-9 17.
8. Safren SA. Duran P. Yovel I. Perlman CA. Sprich S. Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord. 2007; 1 0(3):257-260.
9. Ibrahim el SR. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder. Hum Psychopharmocol. 2002;17(5):225-231.
10. Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559-567.
11. Marcus SC, Wan GJ, Kemner JE. Olfson M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005;159(6):572-578.
12. Faraone SV, Biederman J, Zimmerman B. An analysis of patient adherence to treatment during a 1-year, open-label study of OROS-methyiphenidate in children with ADHD. J Atten Disord. 2007:11(2): 64-73.
13. Winterstein AG, Gerhard T, Shuster J, et al. Utilization of pharmacologic treatment in youth with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother. 2008:42(1):24-31.
14. Pappadopulos E, Jensen PS, Chait AR, et al. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009;48(5):501-510.
15. Olfson M. Marcus S, Wan G. Stimulant dosing for children with ADHD: a medical claims analysis. J Am Acad Child Psychiatry. 2009:48(l): 51-59.
16. Chou WJ, Chou MC, Tzang RF. et at. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Psychiatry Clin Neurosci. 2009:63(2):167-175.
17. Perwien AR, Hall J, Swensen A. Swindle R. Stimulant treatment patterns and compliance in children and adults with newly treated attention-defict/ hyperactivity disorder. J Manag Care Pharm. 2004;10(2): 122-129.
18. Olfson M, Marcus SC. Zhang HF, Wan GJ. Continuity of methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. J Manag Care Pharm. 2007;13(7):570-577.
19. Nierenberg AA, Ostachcr MJ, Borrelli DJ, et at. The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. J Clin Psychiatry. 2006:67(suppl 11):3-7.